Laromin

Clarithromycin, the active ingredient in Laromin, is a macrolide antibiotic presented as an oral dosage form for oral use. It treats bacterial infections such as community‑acquired pneumonia, acute bacterial sinusitis, skin and soft‑tissue infections, and is used in combination regimens for Helicobacter pylori eradication.

GNH USA supplies Laromin as a licensed, GDP‑compliant international pharmaceutical supplier, providing the product to hospitals, pharmacies, clinics and other health‑care institutions worldwide, with adherence to quality standards and regulatory requirements, through reliable logistics networks globally.

Clarithromycin is a macrolide antibiotic used to treat bacterial infections of the respiratory, sinus, skin and gastrointestinal systems.

Community‑acquired pneumonia: eliminates causative bacteria and improves respiratory function. Acute bacterial sinusitis: reduces sinus inflammation and clears infection. Skin and soft‑tissue infections: eradicates susceptible Staphylococcus and Streptococcus species. Helicobacter pylori eradication (in combination therapy): contributes to bacterial clearance as part of multidrug regimens.

Clarithromycin may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Diarrhea: loose stools, sometimes watery. - Abdominal pain: cramping or discomfort. - Altered taste: metallic or bitter sensation.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or anaphylaxis. - Clostridioides difficile‑associated diarrhea: severe colitis risk. - Hepatic dysfunction: elevated liver enzymes or jaundice.

Before prescribing clarithromycin, consider the following precautions.

Assess renal and hepatic function: adjust therapy if impairment is present. Avoid use in patients with known macrolide hypersensitivity: consider alternative agents. Monitor QT interval in patients with cardiac risk factors or concomitant QT‑prolonging drugs. Use caution during pregnancy: weigh benefits against potential risks. Avoid concomitant use with strong CYP3A4 inhibitors: may increase clarithromycin levels. Store at ambient temperature: keep in original container, protect from moisture and light.

Clarithromycin interacts with several medicines; review patient medication lists.

Major Interactions (Avoid): - Erythromycin, ketoconazole, cisapride, and certain statins (simvastatin, lovastatin): may cause serious cardiac or metabolic effects. - Strong CYP3A4 inhibitors (e.g., ritonavir): can markedly increase clarithromycin concentrations.

Moderate Interactions (Monitor Closely): - CYP3A4 inducers (rifampin, carbamazepine): may reduce efficacy. - Warfarin: may enhance anticoagulant effect, requiring INR monitoring. - Digoxin and oral contraceptives: may need dose adjustment or therapeutic monitoring.